Several studies have assessed the expression profiles of UGT genes and their deregulation in human cancers that are derived from drug-metabolizing tissues/organs, including liver cancer [31,32], kidney cancer [20], colon cancer [7,33,34], and gastric cancers [35,36]. Here, SLC35A2 is linked to liver cancer.